Choice and flexibility, for individualised care
Despite NHS efforts to reduce pMDI prescribing, the proportion of pMDI vs DPI use has remained consistent since 2020.1 This highlights challenges associated with non-clinical switching, and the patient need for both devices.1 Our entire UK portfolio of respiratory medicines is certified carbon neutral, offering you the choice and flexibility to address individual patients’ needs today, while helping to protect the planet.2
